Metagenomi, Inc. Common Stock cash flow to debt ratio of -218.64% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Metagenomi, Inc. Common Stock's free cash flow has increased -20.25% from $-112.19M last year to $-89.47M, signaling increasing performance

Metagenomi, Inc. Common Stock's debt to equity ratio is 0.34, which means that the company's assets are healthy financed, signaling financial stability.

Metagenomi, Inc. Common Stock's debt has increased relative to shareholder equity from 0.19 last year to 0.34 today, signaling weakened financials

Metagenomi, Inc. Common Stock has a net cash position, so leverage is healthy.

Metagenomi, Inc. Common Stock earns at least as much interest as it pays. Interest obligations are fully covered.

Metagenomi, Inc. Common Stock's profit margin has decreased (361.73%) in the last year from -149.26% to -689.20%, signaling decreasing performance

Metagenomi, Inc. Common Stock's short-term assets of $165.54M exceed its short-term liabilities of $22.93M

Metagenomi, Inc. Common Stock's return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Metagenomi, Inc. Common Stock's return on equity of -63.65%, is lower than 15.00%, indicating bad performance

Metagenomi, Inc. Common Stock's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Metagenomi, Inc. Common Stock has insufficient public price history to evaluate earnings stability.

Metagenomi, Inc. Common Stock has negative free cash flow, indicating the company is burning cash rather than generating it

Metagenomi, Inc. Common Stock has negative free cash flow, indicating cash burn

Metagenomi, Inc. Common Stock's yearly earnings has decreased 12.57% since last year from $-78.06M to $-87.87M, signaling decreasing performance

Metagenomi, Inc. Common Stock's yearly revenue has decreased 51.79% since last year from $52.30M to $25.21M, signaling decreasing performance

ROIC -65.88% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Metagenomi, Inc. Common Stock's 3-year revenue CAGR of 13.59% is positive, indicating growing revenue over the past 3 years

Metagenomi, Inc. Common Stock has insufficient public price history to evaluate revenue consistency.

Metagenomi, Inc. Common Stock has insufficient public price history to evaluate ROE consistency.

Metagenomi, Inc. Common Stock has insufficient data to evaluate this check.

Metagenomi, Inc. Common Stock has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Metagenomi, Inc. Common Stock is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Metagenomi, Inc. Common Stock has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Metagenomi, Inc. Common Stock has insufficient data to evaluate this check.

Metagenomi, Inc. Common Stock has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Metagenomi, Inc. Common Stock has a price-to-book ratio of 0.41x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Metagenomi, Inc. Common Stock has a price-to-sales ratio of 3.42x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue